The accompanying table presents a quarterly update of my Highly Defensive PerformIdex, with an average beta of 0.72 and a market cap-weighted total return of 7.9% over the past year, outpacing the overall market and ETF peer group -- except for Vanguard Consumer Staples (VDC) ETF with an 8% total return over this period. Two companies received buyout offers in the past three mo...
Amgen reported 2Q08 results that beat consensus analyst estimates and raised its full-year [FY] guidance for earnings and revenue, thanks to much stronger-than-expected sales of its anemia drugs Aranesp and Epogen: 2Q08 Revenue +1% at $3.8 billion [B] vs. $3.58B expected Adjusted Earnings Per Share [EPS] of $1.14 vs. $1.02 expected I...
Price target: 69 Analysts' Recommendation: Buy 30 Days Ago: Hold Analysts' Target: $54 Analysts' Targets Deutsche Bank Securities $52 Accumulate Thursday, June 19, 2008 UBS Securities $49 Hold Friday, March 14, 2008 Friedman, Billings, Ramsey & C $45 Hold Thursday, February 28, 2008 Lehman Brothers $69 Overweight...
Portfolio results thru 8/8/08
- Portfolio at www.updown.com - started 1/11/08
9.8% return includes dividends and commission.
Started socialpicks on 6/30. some stocks here are not in...
Stock update and watch list 7/29/08
- Due to difficulties understanding the socialpicks system regarding changing rating from buy to hold and thus resetting the performance, I wanted to sum...
Take a Close Look at Amgen
- It was a relatively slow day for news coming out of the markets, and there is about as much coverage of Super Bowl commercials as anything else. Perhap...
About Amgen Inc
- Answers.com
